Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. India
  4. NSE India Stock Exchange
  5. Solara Active Pharma Sciences Limited
  6. SocietÓ
    SOLARA   INE624Z01016

SOLARA ACTIVE PHARMA SCIENCES LIMITED

(SOLARA)
Prezzo in differita. Tempo differito NSE India Stock Exchange - 27/09 13:06:12
1647.65 INR   -0.89%
RiassuntoQuotazioniGraficiRatingAgendaSocietÓFinanzaConsensusRevisioniDerivati 
AttivitÓ
Solara Active Pharma Sciences Limited Ŕ un'azienda indiana di produzione di API (Application Programming Interface) orientata al cliente. L'azienda fornisce prodotti a valore aggiunto mantenendo l'attenzione sulle esigenze dei clienti. I suoi servizi includono lo sviluppo sintetico, lo sviluppo analitico, l'ingegneria di processo, il laboratorio chilometrico e la regolamentazione. Le capacitÓ dell'azienda includono ricerca e sviluppo chimico, ricerca e sviluppo analitico, ricerca e sviluppo di processo e qualitÓ.

Numero di dipendenti : 2 575 persone.
Vendite per attivitÓ
20202021Delta
Active Pharmal Ingredient12 508.3094.6%15 638.5097.9% +25.02%
Other541.104.1%411.502.6% -23.95%
Services168.101.3%118.800.7% -29.33%
INR in Milioni
Vendite per regione
2021
Asia Pacific9 067.9056.8%
Europe3 920.0024.5%
North America1 505.909.4%
South America994.106.2%
Global411.502.6%
Rest of the World269.401.7%
INR in Milioni
Dirigenti
Nome Titolo EtÓ Da
Bharath R. Sesha Chief Executive Officer & Managing Director - 2020
Subhash Anand Chief Financial Officer & Executive Director - 2021
Swaminathan Srinivasan Senior VP-Research & Development - -
Sudhir Nambiar, Dr. Chief Scientific Officer - -
Rajesh Salwan Chief Operating Officer - 2020
S. Murali Krishna Secretary & Compliance Officer - 2018
Nirmal Pratap Bhogilal Independent Non-Executive Director 72 2018
Ramakrishnan R. Independent Director 67 2018
Kausalya Santhanam, Dr. Independent Non-Executive Director 52 2018
Aditya Tapishwar Puri Chairman 70 2021
Amministratori
Nome Titolo EtÓ Da
Aditya Tapishwar Puri Chairman 70 2021
Nirmal Pratap Bhogilal Independent Non-Executive Director 72 2018
Ramakrishnan R. Independent Director 67 2018
Kausalya Santhanam, Dr. Independent Non-Executive Director 52 2018
Ankur Nand Thadani Non-Executive Director - 2019
Subhash Anand Chief Financial Officer & Executive Director - 2021
Sheela Bhogilal Director 66 -
Arun Kumar Pillai Non-Executive Director - 2021
Rajender Juvvadi Rao Vice Chairman - 2021
Vineeta Rai Independent Director 75 2021
Azioni
Voto QuantitÓFlottanteAutocontrolloFlottante totale
Azione A 1 35 929 767 13 568 095 37.8% 0 0.0% 37.8%
Azionisti
NomeAzioni%
TPG Growth LLC 5 466 816 15,2%
Vistra Group Ltd. 4 967 784 13,8%
Arun Kumar Pillai 3 168 463 8,82%
Karuna Business Solutions LLP 2 812 121 7,83%
Pronomz Ventures LLP 2 121 243 5,90%
Srjr Enterprise LLP 1 700 100 4,73%
Keerthapati Ramaraju Ravishankar 1 325 260 3,69%
SBI Funds Management Pvt Ltd. 1 158 217 3,22%
Think Investments LP 1 079 349 3,00%
Chayadeep Ventures LLP 1 005 000 2,80%
Coordinate societÓ
Solara Active Pharma Sciences Ltd.
3rd & 4th Floor, Batra Centre
No.28, Sardar Patel Road
Guindy
Chennai, Tamil Nadu 600032

Phone : +91.44.43446700
Fax : +91.44.22350278
Web : http://www.solara.co.in
Portafoglio di marchi
In collaborazione conAllbrands.markets
Pi¨ marchi di Solara Active Pharma Sciences Limited
Settore Prodotti farmaceutici - Altri
Var. 1genCapi. (M$)
SOLARA ACTIVE PHARMA SCIENCES LIMITED39.52%809
JOHNSON & JOHNSON4.44%432 675
ROCHE HOLDING AG10.16%321 605
PFIZER, INC.19.37%246 358
NOVO NORDISK A/S50.45%231 485
ELI LILLY AND COMPANY37.22%210 037
ABBVIE INC.-0.07%189 211
ASTRAZENECA PLC20.77%187 304
MERCK & CO., INC.-10.01%186 334
NOVARTIS AG-8.00%186 020
BRISTOL-MYERS SQUIBB COMPANY-2.90%133 838
AMGEN INC.-7.09%121 299
SANOFI4.22%120 553
GLAXOSMITHKLINE PLC3.43%94 962
CHUGAI PHARMACEUTICAL CO., LTD.-23.17%63 921
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED0.43%53 563
BAYER AG-3.45%53 487
DAIICHI SANKYO COMPANY, LIMITED-12.76%53 247
JIANGSU HENGRUI MEDICINE CO., LTD.-45.36%49 081
ASTELLAS PHARMA INC.17.63%31 844